首页> 外文期刊>Cancer causes and control: CCC >Reproductive factors in relation to breast cancer characterized by p53 protein expression (United States).
【24h】

Reproductive factors in relation to breast cancer characterized by p53 protein expression (United States).

机译:与乳腺癌有关的生殖因子,特征在于p53蛋白的表达(美国)。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To evaluate the potential etiologic heterogeneity of breast cancer by examining whether associations with reproductive and other personal characteristics differed by p53 protein expression status. METHODS: Data from the Carolina Breast Cancer Study, a population-based, case-control study of 861 cases and 790 controls, were utilized. Immunohistochemical staining for the p53 protein was performed on 638 archived tumor specimens; 46% of cases were classified as p53+. Two separate unconditional logistic regression models were used to calculate odds ratios (OR) and 95% confidence intervals (CI) for p53+ and p53- breast cancer relative to controls for reproductive and other personal characteristics. Analyses were performed separately for younger (< or = 45 years) and older (>45 years) women. RESULTS: Risk factor profiles largely overlapped for p53+ and p53- breast cancer, with the exception of oral contraceptive (OC) use among younger women and a family history of breast cancer. Prolonged OC use was more strongly associated with p53+ breast cancer [OR 3.1 (95% CI: 1.2-8.1) than p53- breast cancer (OR 1.3 (95% CI: 0.6-3.2)] among younger women only. A first-degree family history of breast cancer was associated with p53+ breast cancer among younger women [OR 1.5 (95% CI: 1.0-2.2)] and older women [OR 1.4 (95% CI: 0.9-2.3)], but not p53- breast cancer in either age-group. CONCLUSIONS: These results provide little evidence of breast cancer heterogeneity as classified by p53 expression status. However, although not statistically significant, OC use among younger women and family history of breast cancer may operate through a pathway involving p53 alterations to increase risk of breast cancer.
机译:目的:通过检查与生殖和其他个人特征的关联是否因p53蛋白表达状态而异,以评估乳腺癌的潜在病因异质性。方法:利用来自卡罗来纳州乳腺癌研究的数据,该研究是基于人群的861例病例和790例对照病例对照研究。对p53蛋白的免疫组织化学染色是在638个存档的肿瘤标本上进行的。 46%的病例被分类为p53 +。相对于生殖和其他个人特征的对照,使用两个单独的无条件逻辑回归模型来计算p53 +和p53-乳腺癌的比值比(OR)和95%置信区间(CI)。分别对年轻(≤45岁)和年长(> 45岁)女性进行了分析。结果:p53 +和p53-乳腺癌的危险因素特征在很大程度上重叠,但较年轻的女性使用口服避孕药(OC)和有乳腺癌家族史的除外。仅在年轻女性中,长时间使用OC与p53 +乳腺癌[OR 3.1(95%CI:1.2-8.1)]的关联性强于p53-乳腺癌(OR 1.3(95%CI:0.6-3.2)]。乳腺癌的家族史与年轻女性[OR 1.5(95%CI:1.0-2.2)]和老年女性[OR 1.4(95%CI:0.9-2.3)]与p53 +乳腺癌相关,但与p53-乳腺癌无关结论:这些结果几乎不能提供按p53表达状态分类的乳腺癌异质性证据,但是,尽管在统计学上不显着,但年轻女性的OC使用率和乳腺癌家族史可能通过涉及p53改变的途径起作用增加患乳腺癌的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号